2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用

2020-02-14 美国妇科肿瘤学会 Gynecol Oncol. 2020 Feb 14.

2020年2月,美国妇科肿瘤学会(SGO)发布了关于激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用的实践声明。本文的主要目的是澄清使用激素治疗对妇科肿瘤确诊患者以及妇科肿瘤高危患者的影响。

中文标题:

2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用

英文标题:

Hormone therapy (HT) in women with gynecologic cancers and inwomen at high risk for developing a gynecologic cancer: A Society ofGynecologic Oncology (SGO) clinical practice statement

发布机构:

美国妇科肿瘤学会

发布日期:

2020-02-14

简要介绍:

2020年2月,美国妇科肿瘤学会(SGO)发布了关于激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用的实践声明。本文的主要目的是澄清使用激素治疗对妇科肿瘤确诊患者以及妇科肿瘤高危患者的影响。

 

拓展指南:激素相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用)] GetToolGuiderByIdResponse(projectId=1, id=f0e3e1c001868257, title=2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用, enTitle=Hormone therapy (HT) in women with gynecologic cancers and inwomen at high risk for developing a gynecologic cancer: A Society ofGynecologic Oncology (SGO) clinical practice statement, guiderFrom=Gynecol Oncol. 2020 Feb 14., authorId=null, author=, summary=2020年2月,美国妇科肿瘤学会(SGO)发布了关于激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用的实践声明。本文的主要目的是澄清使用激素治疗对妇科肿瘤确诊患者以及妇科肿瘤高危患者的影响。 , cover=, journalId=null, articlesId=null, associationId=1177, associationName=美国妇科肿瘤学会, associationIntro=The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women&rsquo;s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations., copyright=0, guiderPublishedTime=Fri Feb 14 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年2月,美国妇科肿瘤学会(SGO)发布了关于激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用的实践声明。本文的主要目的是澄清使用激素治疗对妇科肿瘤确诊患者以及妇科肿瘤高危患者的影响。 </P> <P> </P>拓展指南:<strong>与<font color=red>激素</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=446bb1c001863323" title="2020 AA/RCP/SE指南:肾上腺功能不全患者围术期糖皮质激素管理" target=_blank>2020 AA/RCP/SE指南:肾上腺功能不全患者围术期糖皮质激素管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6361d1c0018561d3" title="2020 CAP临床指南:乳腺癌雌激素和孕激素受体检测" target=_blank>2020 CAP临床指南:乳腺癌雌激素和孕激素受体检测</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b11861c001839356" title="2019 多学科共识文件:转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测" target=_blank>2019 多学科共识文件:转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b67ca1c0018332d6" title="面部激素药毒(糖皮质激素依赖性皮炎)中医治疗专家共识" target=_blank>面部激素药毒(糖皮质激素依赖性皮炎)中医治疗专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=4ec471c00180e9d2" title="2019 ACOG委员会意见:青少年高雄激素的筛查和管理(No.789)" target=_blank>2019 ACOG委员会意见:青少年高雄激素的筛查和管理(No.789)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%BF%80%E7%B4%A0" target=_blank>有关激素更多指南</a></ul>, tagList=[TagDto(tagId=3608, tagName=激素治疗), TagDto(tagId=1983, tagName=妇科肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13249, appHits=174, showAppHits=11, pcHits=3457, showPcHits=10514, likes=19, shares=7, comments=4, approvalStatus=1, publishedTime=Mon Feb 24 23:49:02 CST 2020, publishedTimeString=2020-02-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 24 23:49:02 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:09:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用)])
2020 SGO临床实践声明:激素治疗(HT)在妇科肿瘤以及妇科肿瘤高危女性中的应用
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198288, encodeId=df85119828810, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Mar 01 10:08:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010974, encodeId=392210109e4fb, content=😝😝😝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:51:35 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010972, encodeId=2fd110109e260, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:50:57 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954166, encodeId=c552954166dd, content=好文章!受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Apr 06 11:53:50 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2022-03-01 屋顶瞄爱赏月

    学习学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198288, encodeId=df85119828810, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Mar 01 10:08:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010974, encodeId=392210109e4fb, content=😝😝😝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:51:35 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010972, encodeId=2fd110109e260, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:50:57 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954166, encodeId=c552954166dd, content=好文章!受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Apr 06 11:53:50 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-08-24 Luciano

    😝😝😝

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198288, encodeId=df85119828810, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Mar 01 10:08:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010974, encodeId=392210109e4fb, content=😝😝😝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:51:35 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010972, encodeId=2fd110109e260, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:50:57 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954166, encodeId=c552954166dd, content=好文章!受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Apr 06 11:53:50 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-08-24 Luciano

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198288, encodeId=df85119828810, content=学习学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue Mar 01 10:08:35 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010974, encodeId=392210109e4fb, content=😝😝😝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:51:35 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010972, encodeId=2fd110109e260, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKU4B2MceUmMlO5n2ksKqS1l2VdYwskjN79GACsjb6m7IOmNRj1AiaianDSPL5SYR9l6z5xKoV78ahw/132, createdBy=7e345141477, createdName=Luciano, createdTime=Tue Aug 24 14:50:57 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954166, encodeId=c552954166dd, content=好文章!受益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Apr 06 11:53:50 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-06 湘雅科教

    好文章!受益匪浅。

    0